1)Linda NG and Libertino JM:Adrenocortical carcinoma:diagnosis, evaluation and treatment. J Urol 169:5-11, 2003
2)Barzon L, Scaroni C, Sonino N, et al:Risk factors and long-term follow-up of adrenal incidentalomas. J Clin Endocrinol Metab 84:520-528, 1999
3)Cohn K, Gottesman L and Brennan MF:Adreno-cortical carcinoma. Surgery 100:1170-1177, 1986
4)Iihara M and Obara T:Diagnosis and treatment for adrenocortical Carcinoma. J Cancer Chemother 31:342-345, 2004
5)Bonacci R, Gigliotti A, Baudin E, et al:Cytotoxic therapy with etoposide and cisplatin in advanced adrenocortical carcinoma. Br J Cancer 78:546-549, 1988
6)Berruti A, Terzolo M, Pia A, et al:Mitotane associated with etoposide, doxorubicin, and cisplatin in the treatment of advanced adrenocortical carcinoma. Cancer 83:2194-2200, 1988
7)Weiss LM, Medeiros LJ and Vickery AL:Pathologic features of prognostic significance in adrenocortical carcinoma. Am J Surg Pathol 13:202-206, 1989